塑造果树的结构: 1,3,4-oxathiazol-2-one衍生物作为MdDOX-Co活性抑制剂
Yuta Kitajima1, Taiki Inoue1, Kojiro Kawada1
1Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, JAPAN.
Bioscience, biotechnology, and biochemistry
|July 17, 2025
概括
研究人员发现了针对MdDOX-Co基因的新化学抑制剂,以控制果树结构. 这些化合物促进垂直生长,帮助高密度种植,并可能促进果产量.
科学领域:
- 植物科学 植物科学
- 农业化学 农业化学
- 分子生物学分子生物学
背景情况:
- 全球果生产面临劳动力短缺,需要创新的果园管理策略.
- 由MdDOX-Co基因调节的柱状果生长,促进了高密度的种植和高效的收获.
- MdDOX-Co基因编码了一种对植物发育至关重要的二氧化酶 (2ODD) 酶.
研究的目的:
- 为了确定MdDOX-Co酶的选择性化学抑制剂.
- 探索用于调节果树结构和生产力的新型农业化学品.
主要方法:
- 基于C6的类似物与1,3,4-oxathiazol-2-one异环环的合成.
- 在体外评估对MdDOX-Co.Co.的抑制活性.
- 在过度表达MdDOX-Co.的阿拉比多普西斯种苗延长的评估.
- 对相关的2ODD酶进行结构-活性关系分析和选择性测定.
- 分子建模以预测化合物与MdDOX-Co活性部位的相互作用.
主要成果:
- 含有1,3,4-oxathiazol-2-one核心的化合物在体外表现出强烈的MdDOX-Co.抑制.
- 这些抑制剂促进了MdDOX-Co过度表达Arabidopsis的苗木延长.
- 结构-活性分析证实了1,3,4-oxathiazol-2-one环的重要作用,允许侧链修改.
- 选择性测试显示,对其他2ODD酶的非目标效应很小.
- 分子建模支持化合物与MdDOX-Co活性部位的结合.
结论:
- 1,3,4-oxathiazol-2-one化合物是MdDOX-Co.的有效和选择性的抑制剂.
- 这些发现为开发MdDOX-Co向农业化学品提供了基础.
- 化学调节果树架构可以提高种植的生产力.
相关概念视频
Structure-Activity Relationships and Drug Design
1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.2K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.2K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
645
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
645
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
321
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
321


